Solid Tumour

Explore clinical trials studying Solid Tumour. Study availability and eligibility vary by location and protocol.

17 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Solid Tumour trial results

Completed

A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours

NCT04958226

Conditions: Solid Tumour
Locations: Research Site Aurora, Colorado, United States

Research Site Durham, North Carolina, United States

Research Site Cleveland, Ohio, United States

Research Site Pittsburgh, Pennsylvania, United States

View Trial Details

Completed

A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole

NCT04121910

Conditions: Solid Tumour
Locations: Research Site Glendale, California, United States

View Trial Details

Completed

An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers

NCT02648490

Conditions: Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations: Henlix, Inc. Fremont, California, United States

Linkou Chang Gung Memorial Hospital Taoyuan, Taiwan

View Trial Details

Completed

Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor

NCT02086721

Conditions: Solid Tumour
Locations: MAASTRO clinic Maastricht, Limburg, Netherlands

View Trial Details

Completed

A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours

NCT01489826

Conditions: Neoplasms, Solid Tumour
Locations: Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom

Northern Centre for Cancer Care, Freeman Hospital, Newcastle-upon-Tyne, UK Newcastle upon Tyne, Tyne and Wear, United Kingdom

The Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

View Trial Details

Completed

Nivestim™ in Treatment of Malignant Diseases

NCT01627990

Conditions: Malignant Haematological Tumour, Primary or Secondary Prophylactic Treatment, Solid Tumour
Locations: Facharzt für Innere Medizin, Onkologie, Hämatologie Ahaus, Germany

Studienzentrum Hämatologie/Onkologie/Diabetologie Aschaffenburg, Germany

Facharzt für Innere Medizin Hämatologie / Onkologie Bad Säckingen, Germany

MediOnko-Institut GbR Berlin, Germany

View all 48 locations

View Trial Details

Completed

Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors

NCT01300468

Conditions: Solid Tumour
Locations: Scottsdale Clinical Research Institute Scottsdale, Arizona, United States

The Johns Hopkins University Baltiomore, Maryland, United States

View Trial Details

Solid Tumour

Solid Tumour trial results

A Study to Assess the Effect of Capivasertib on Midazolam in Patients With Advanced Solid Tumours

A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole

An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of HLX07,in Patients With Advanced Solid Cancers

Phase I Clinical Study Combining L19-IL2 With SABR in Patients With Oligometastatic Solid Tumor

A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours

Nivestim™ in Treatment of Malignant Diseases

Study of PHA-848125AC in Adult Patients With Advanced/Metastatic Solid Tumors

Related conditions